iVue Normative Database receives FDA clearance

Article

Optovue has received FDA 510(k) clearance of the Normative Database for its iVue SD-OCT system. The Normative Database analyzes information to be used as clinical reference in the diagnosis and management of ocular health and disease.

Fremont, CA-Optovue Inc. has received FDA 510(k) clearance of the Normative Database for its iVue SD-OCT system. The Normative Database processes information to be used as a clinical reference to aid in the diagnosis and management of ocular health and disease.

The iVue Normative Database provides quantitative comparisons of the retina, retinal nerve fiber layer, ganglion cell complex, and optic disc measurements to aid the practitioner in evaluating various ocular pathologies. After scans are captured, the normative comparison analysis adjusts for the patient’s age, optic disc size (for optic nerve head scans only), and scan signal strength. Symmetry and change analyses combined with normative comparisons support patient evaluation and management.

The Normative Database is included with any iVue SD-OCT system purchase. A new software update will be provided free-of-charge to all current iVue owners of record.

The update is expected to be made available in early March.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Susana Marcos, PhD, discusses the implications her research presents for the role optical coherence tomography (OCT) could play in presbyopia and myopia accommodation efforts.
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
Karl Stonecipher ASCRS 2025
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.